Stable Clinical Course of Chronic Obstructive Pulmonary Disease Patients in the Era of Double Bronchodilator Therapy: A Single Referral Center Experience

Despite clinical benefits of long-acting muscarinic antagonist (LAMA)/long-acting beta2-agonist (LABA) double bronchodilator therapy, there has been limited evidence for treatment change from LAMA/LABA to inhaled corticosteroid (ICS)-containing therapy. This study aimed to assess the rate of ICS-con...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Sun Hye, Kang, Noeul, Cho, Juhee, Choi, Yeonseok, Cho, Hyun Kyu, Choi, Hye Sook, Kim, Hojoong, Lim, Jun Hyeok, Park, Hye Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465249/
https://www.ncbi.nlm.nih.gov/pubmed/32781649
http://dx.doi.org/10.3390/jcm9082547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465249/
https://www.ncbi.nlm.nih.gov/pubmed/32781649
http://dx.doi.org/10.3390/jcm9082547

Ejemplares similares